Literature DB >> 7831173

Effect of acute cytomegalovirus infection on drug-induced SLE.

A Schattner1, Z Sthoeger, D Geltner.   

Abstract

A 58 year old woman developed systemic symptoms, interstitial lung disease, splenomegaly, leukopenia and anti-histone and anti-nuclear antibodies (ANA), while treated with hydralazine for hypertension. Five months after presentation she was admitted with high fever, skin rash and atypical lymphocytosis due to acute cytomegalovirus (CMV) infection. Worsening leukopenia and increased ANA were found, and high titres of anti-DNA antibodies, anti-cardiolipin antibodies and rheumatoid factors appeared. Hydralazine was stopped and the patient gradually became asymptomatic. All autoantibodies spontaneously disappeared (over 16 weeks), and the white cell count and spleen size became normal. The patient was found to be a slow acetylator and to have both HLA-DR4 and selective IgA deficiency. Thus, a multifactorial genetic susceptibility to develop drug-induced lupus was brought out in stages first by hydralazine and then by CMV, yet all manifestations and autoantibodies resolved spontaneously, demonstrating the complex interplay of varied environmental factors with a genetic predisposition in the pathogenesis of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7831173      PMCID: PMC2397766          DOI: 10.1136/pgmj.70.828.738

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  12 in total

1.  Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection.

Authors:  P Andersen; H K Andersen
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

2.  Immunostimulation by cytomegalovirus (CMV): helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donors.

Authors:  A Yachie; G Tosato; S E Straus; R M Blaese
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

3.  Drug-related lupus.

Authors:  E Hess
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

4.  Guillain-Barré syndrome associated with cytomegalovirus infection.

Authors:  I K Hart; P G Kennedy
Journal:  Q J Med       Date:  1988-05

5.  Lymphocyte alteration by procainamide: relation to drug-induced lupus erythematosus syndrome.

Authors:  H G Bluestein; N J Zvaifler; M H Weisman; R F Shapiro
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

Review 6.  Virus-induced autoimmunity.

Authors:  A Schattner; B Rager-Zisman
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

7.  Anti-cardiolipin antibodies and HIV infection.

Authors:  C Maclean; P J Flegg; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

8.  The lupus syndrome induced by hydralazine: a common complication with low dose treatment.

Authors:  H A Cameron; L E Ramsay
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

9.  Hydralazine, antinuclear antibodies, and the lupus syndrome.

Authors:  R Mansilla-Tinoco; S J Harland; P J Ryan; R M Bernstein; C T Dollery; G R Hughes; C J Bulpitt; A Morgan; J M Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27

10.  Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.

Authors:  J R Batchelor; K I Welsh; R M Tinoco; C T Dollery; G R Hughes; R Bernstein; P Ryan; P F Naish; G M Aber; R F Bing; G I Russell
Journal:  Lancet       Date:  1980-05-24       Impact factor: 79.321

View more
  2 in total

Review 1.  Systematic review of case reports of antiphospholipid syndrome following infection.

Authors:  N Abdel-Wahab; M A Lopez-Olivo; G P Pinto-Patarroyo; M E Suarez-Almazor
Journal:  Lupus       Date:  2016-04-07       Impact factor: 2.911

2.  Acute Low-Dose Hydralazine-Induced Lupus Pneumonitis.

Authors:  Sarah K Holman; Donique Parris; Sarah Meyers; Jason Ramirez
Journal:  Case Rep Pulmonol       Date:  2017-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.